The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot ...

A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...

Spending through the 340B Drug Pricing Program rose by 565% between 2010 and 2021, increasing from $6.6 billion to $43.9 billion, according to a report from the Congressional Budget Office. In 2021, ...

For-profit drug manufacturers want to change how the 340B Drug Pricing Program works, but going from upfront savings to back-end rebates will kill nonprofit health providers.

More than 160 lawmakers have urged the Trump administration to abandon a newly announced pilot program that would allow ...

Congress is considering a new bill that, in theory, would boost low-income patients’ - especially Latinos’ - access to ...

AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.” ...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...